Radiation Absorbed Dose Evaluation of [177Lu] Lu-DOTMP Radiopharmaceutical in Man Based On Biodistribution Data in Wistar Rats

Radiation Absorbed Dose Evaluation of [177Lu] Lu-DOTMP Radiopharmaceutical in Man Based On Biodistribution Data in Wistar Rats

Introduction: Bone metastasis is the advanced stage of solid malignant tumors. Bone-avid beta-emitting radiopharmaceuticals such as lutetium-177-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid ([177Lu]Lu-DOTMP) are effectively utilized for bone pain palliation. Radiation absor...

Full description

Saved in:

Bibliographic Details
Main Authors:	Reza Bagheri, Hassan Ranjbar
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2024-12-01
Series:	Iranian Journal of Medical Physics
Subjects:	radiopharmaceuticals bone metastasis radiation absorbed dose effective dose
Online Access:	https://ijmp.mums.ac.ir/article_24195_40a703e81b09f37cfbdecaa50ba70df3.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Features and Practical Aspects of Radiochemical Purity Determination of Receptor-Specific Lu-177 Radiopharmaceuticals as Exemplified by [<sup>177</sup>Lu]Lu–PSMA-617
by: A. A. Larenkov, et al.
Published: (2022-12-01)

Estimation of absorbed doses in patients’ organs from the released radionuclide-label during radionuclide therapy with <sup>225</sup>Ac
by: A. E. Petrova, et al.
Published: (2022-04-01)

177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
by: Mathilde Ponchelle, et al.
Published: (2025-05-01)

Stability in the production and transport of 177Lu labelled PSMA
by: Cristian Antonio Wieczorek Villas Boas, et al.
Published: (2021-03-01)

Patient organ and effective dose estimation in radionuclide therapy with <sup>223</sup>Ra -dichloride
by: L. A. Chipiga, et al.
Published: (2020-12-01)

Optimizing Standardization Systems and Standardizing Clinical Practice: Interpretation of Quality Standards for Medical 68Ge/68Ga Generators and 68Ga Radiopharmaceuticals and Quality Standards for Medical 177Lu and Its Radiopharmaceuticals
by: LAI Yuxin, et al.
Published: (2025-07-01)

Animal-based radiation absorbed dose evaluation of holmium-166 labeled hydroxyapatite particulates in liver malignancies
by: Reza Bagheri, et al.
Published: (2025-01-01)

Comparison of tumour segmentation methods for dosimetry in [177Lu]Lu-PSMA I&T treated patients with metastatic castration resistant prostate cancer
by: Peter Frøhlich Staanum, et al.
Published: (2025-07-01)

Radiosensitization of the Gold, Silver, and Gadolinium Nanoparticles in 177Lu Radionuclide Radiation Field in Microscopic and Macroscopic Scales in the Liver Radionuclide Therapy
by: Wrya Parwaie, et al.
Published: (2025-07-01)

Toward the standardization of radiopharmaceutical therapies: a technical note evaluating a clinical dosimetry workflow for single-time-point 177Lu SPECT/CT-based therapies
by: Taehyung Peter Kim, et al.
Published: (2025-08-01)

ON THE RELATIONSHIP BETWEEN AMBIENT DOSE EQUIVALENT AND ABSORBED DOSE IN AIR IN THE CASE OF LARGE-SCALE CONTAMINATION OF THE ENVIRONMENT BY RADIOACTIVE CESIUM
by: V. P. Ramzaev, et al.
Published: (2015-10-01)

The analysis of impact of irregularity in radionuclide coating of scaffold on the distribution of absorbed dose produced by grid of microsources
by: N. A. Nerosin, et al.
Published: (2015-09-01)

DETERMINATION AND EVALUATION OF LONG-TERM ABSORBED RADIATION DOSES OF RADIATION WORKERS WORKING IN TARGETED RADIONUCLIDE THERAPIES
by: Nazenin İpek Işıkcı, et al.
Published: (2023-02-01)

Results of individual dosimetric monitoring of the hands skin for personnel engaged in working with radiopharmaceuticals
by: E. N. Shleenkova, et al.
Published: (2025-01-01)

Study on the Radiation Dose Distribution of Abdominal CT Scans Based on Dose Simulation Humans
by: Xiaolong NI, et al.
Published: (2024-11-01)

Dose-Dependent Cellular Phenotypic Change Induced by <sup>177</sup>Lu-Oxodotreotide Treatment in IMR-32 Cells
by: Shuai Xue, et al.
Published: (2025-06-01)

First-in-human experience of radiopharmaceutical therapy with [177Lu]Lu-DOTATATE in patients with advanced multiple myeloma
by: Wendy Delbart, et al.
Published: (2025-07-01)

New Deformity Outline on the Breast Radiation Therapy for diminishing Absorbed Dose Ratio
by: Abdollah Khorshidi, et al.
Published: (2023-07-01)

About the requirements of regular monitoring of doses for the eye lens of the staff working with radiopharmaceuticals
by: E. N. Shleenkova, et al.
Published: (2021-10-01)

Development and implementation of a measurement system for PTW water phantom in the determination of absorbed dose to water
by: Andreina Leon, et al.
Published: (2025-01-01)

Assessment of the absorbed doses in the fetus from the computed tomography of the chest for the pregnant women
by: A. V. Vodovatov, et al.
Published: (2021-10-01)

Investigation of fetal absorbed dose in V/Q scan in three trimesters of pregnancy using Monte Carlo simulation
by: Shahabeddin Vakili, et al.
Published: (2021-10-01)

IDAC-Dose 2.2, an internal dosimetry software for diagnostic nuclear medicine based on the latest ICRP adult and paediatric reference computational phantoms
by: Martin Andersson, et al.
Published: (2025-06-01)

Estimation of Absorbed Dose in Head CT scans Based on mA and mAs Modulation and Volumetric Air Kerma Index (CVOL) in Petrolina/PE, Brazil
by: Jamerson Silva de Albuquerque Junior, et al.
Published: (2021-06-01)

Radiation exposure and protection advice after [177Lu]Lu-DOTA-TATE therapy in China
by: Fei Liu, et al.
Published: (2024-11-01)

Metastatic Bone Pain Palliation using 177 Lu-Ethylenediaminetetramethylene Phosphonic Acid
by: Mehrosadat Alavi, et al.
Published: (2015-04-01)

3D-Printed Organ-Realistic Phantoms to Verify Quantitative SPECT/CT Accuracy for 177Lu-PSMA-617 Treatment Planning
by: Lydia J. Wilson, et al.
Published: (2025-04-01)

Brief Analysis of the Validation of Analytical Methods for Radiopharmaceuticals
by: Mengyi CHEN, et al.
Published: (2024-12-01)

Reconstruction of the absorbed dose of ionizing radiation for helophytes in the water bodies of the near emergency zone at the Chornobyl NPP
by: V. V. Belyaev, et al.
Published: (2020-12-01)

Particularities of dose load forming for the fish in Kanev reservoir
by: O. M. Volkova, et al.
Published: (2010-03-01)

Dynamics of decrease of the gamma dose rate in air in rural settlements of the Bryansk region (Russia) in the remote period after the Chernobyl accident
by: V. P. Ramzaev, et al.
Published: (2020-03-01)

Optimization of PSMA-I&T radiolabeling with 177Lu
by: Luiza Mascarenhas Balieiro, et al.
Published: (2025-06-01)

Patient-specific phantoms versus reference phantoms: a preliminary comparison on organs dose distribution
by: Isabelle Viviane Batista de Lacerda, et al.
Published: (2018-07-01)

Blood-based transcriptomic biomarkers for response to [177Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors
by: Hyunpil Sung, et al.
Published: (2025-08-01)

Patient dose reduction by changing the amount of 18F-FDG radiopharmaceutical injected
by: Fernanda Guerra Paiva, et al.
Published: (2019-02-01)

Multifactorial analysis of radiochemical purity in high-activity 177Lu-labeled theranostics: impact of precursor source, 177Lu form, and production parameters
by: William Hunt, et al.
Published: (2025-07-01)

Regulation of Radiopharmaceutical Products
by: V. V. Kosenko, et al.
Published: (2022-12-01)

Radiation-sensitive film compositions for measuring absorbed doses within the 100-1000 Gy range
by: V. P. Tenishev, et al.
Published: (2019-11-01)

Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise
by: D. V. Goryachev, et al.
Published: (2025-02-01)

TO THE QUESTION OF RADIATION PROTECTION ENSURING OF PASSENGERS TAKEN RADIOPHARMACEUTICALS DURING TRANSPORTATION BY RAILWAY TRANSPORT
by: N. N. Artemyeva, et al.
Published: (2015-08-01)